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1. Introduction 
Chinese medicine is an unique medical system, among which Chinese medicines (including 
Chinese medicinal plants, Chinese animal drugs, Chinese mineral drugs and composite 
formulae) have been used in main stream medical health care in China for years of thousands 
and have been accepted by many countries as complemental and alternative medicine. As one 
of the major traditional medicines and Ethnomedicines in the world, Chinese medicines as a 
resource and materials for unmet medical needs have been attracted by scientists in medical, 
pharmaceutical, biomedical engineering and life sciences. The challenges in safety (such as 
Aristolochic acid nephropathy, Chinese medicines adverse reaction and herb-drug 
interaction), quality control (like batch-to-batch reliable, contamination pesticide and heavy 
metals) and green enviroments (protection of endangerous species from animal and plants) 
have also become emerging issues. In the past decades, chemical and pharmacological profiles 
of many Chinese medicines have been extensively studied. In this chapter, we focus on 
advanced progress in molecular and celluar mechanism studies on anticancer action of 
Chinese medicines by trend prediction from top journals of Chinese medicine, ethnomedicine, 
alternative and complemental medicine. 12 representative Chinese medicines were selected in 
this chapter (Rhizoma coptidis, arsenic, Rhizoma Curcuma longae, Radis stephaniae 
tetrandrae, Radix tripterygii wilfordii, Radix scutellariae, Herba artemisiae annuae, Radix 
ginseng, Radix notoginseng, Radix astragali, Radix angelicae senensis and Radix salviae 
miltiorrhizae) and we reviewed the recent progress in order to understand their 
pharmacological action, active chemical ingredients and application of new approaches 
(genomics, proteomics and metabolics). We concentrated on the cellular and molecular 
mechanisms of the therapeutic actions of these Chinese medicines and introduced the major 
active chemical ingredients in relation to therapeutic values. These Chinese medicines can be 
used in treatment of cancer. After reviewing hot Chinese medicines in treatment of cancer in 
this chapter, we hope it will lead to further exploration of Chinese medicines by advanced 
scientific technology in drug discovery for treating cancer.  
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2. Important  
This chapter reviewed the recent progress on Chinese medicines in the cellular and 
molecular mechanism studies and the major active chemical ingredients of Chinese 
medicines in relation to therapeutic values in order to understand their pharmacological 
action, active chemical ingredients and application of new approaches. We noted that the 
cellular and molecular mechanisms and the major active chemical ingredients of Chinese 
medicines have been deeply and widely studied which provide a useful information for 
new drug development and Chinese medicine clinical practice, but the challenges in safety 
(such as Aristolochic acid nephropathy, Chinese medicines adverse reaction and herb-drug 
interaction), quality control (like batch-to-batch reliable, contamination pesticide and heavy 
metals) and green enviroments (protection of endangerous species from animal and plants) 
have also become emerging issues. On the other hand, research mainly focused on sigle 
Chinese medicines in the past decades, we should do more studies on composite fomulae 
(consist of over two single Chinese medicines) by using new technologies, such as “Omics” 
technologics and system biology to get more evidences for Chinese medicine practice and 
new drug development in the future. 
3. The structure of this chapter 
The selected twelve Chinese medicines cover the following contents: 
i. Name of the herb: Common names, botanical name, family, origin, distribution, 
commercially cultivated or wild, traditional use in Chinese medicine clinical practice 
ii. General chemical and pharmacological profiles  
iii. Mechanism studies on anticancer effect of Chinese medicines in in vitro and in vivo 
study 
iv. Adverse reactions 
v. References 
4. The contents of this chapter 
4.1 Rhizoma coptidis (Huanglian in Chinese) 
Coptis Rhizome (CR) is the dried rhizome of Coptis chinensis Franch (Ranunculaceae). Its 
Chinese name is huanglian, which was first recorded in Shen Nong Ben Cao Jing (Shen 
Nong’s Materia Medica, 220 A.D.) Other two species of Coptis Rhizome (Coptis deltoidea C. 
Y. Cheng et Hsiao. and Coptis teetoides C. Y. Cheng (or Coptis teeta Wall.) were also 
specified in the Chinese Pharmacopoeia (The State Pharmacopoeia Commission of the P.R. 
China, 2005). It is native to Sichuan, Hubei, Xizang, Shanxi, and Jiangxi Province of China. 
The source of Huanglian can be obtained from wild species of or cultivated plants. The GAP 
base of Huanglian in China is located in Chongqing, Hubei. Traditionally, CR can be used in 
treatment of diseases like diarrhea, inflammation of the eye, and women’s abdomen 
ailments caused by damp-heat. 
Raw material of CR mainly includes a series of alkaloids, such as berberine, coptisine, 
epiberberine, berberrubine, palmatine, columbamine, jarorrhizine, worenine, magnoflorine, 
groelandicine, berberastine, oxyberberine and thalifendine ect. Other chemicals in CR 
include ferulic acid, obakunone and obakulactone etc. Berberine is the main component and 
is credited as criteria for quality control of CR in China Pharmacopeia (Edition 2005). CR 
and berberine have been used for treatment of intestinal infections (acute gastroenteritis, 
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cholera and bacterial diarrhea) by their antibacterial and antiviral effects, treatment of 
hypercholesterolemic patients and type 2 diabetes by hypolipidemic effects, and various 
experimental heart diseases, such as heart failure,cardiac dysfunction, pressure-overload 
induced cardiac hypertrophy (Feng et al., 2010). Berberine may help in neuropsychiatric 
diseases by inhibiting Prolylligopeptidase, a peptidase associated to schizophrenia, bipolar 
affective disorder and related conditions (Tarrago et al., 2007).  
Recently, the most attractive pharmacological effect of CR and berberine is its anticancer 
activities (Tang et al., 2009). CR and berberine were used for prevention and treatment of 
human cancers, such as nasopharyngeal carcinoma (NPC), cholangecarsinoma with 
complication of liver cancer, and phase I study of CR (Chinese Herb) in patients with 
advanced solid tumors (Tian et al., 2000; Feng et al., 2008; 
http://cancer.gov/clinicaltrials/MSKCC-00061). Berberine is the principal active compound 
of anticancer effect in CR (Hara et al., 2005). There are many reports showing that berberine 
could inhibit proliferation of cancer cells in gastric cancer, leukemia, melanoma, liver cancer, 
colorectal cancer, pancreas cancer, oral cancer, breast cancer, cervical cancer, lung cancer, 
NPC and prostate cancer cell line models and may have potential chemotherapeutic 
properties against human cancers (Lin et al., 2006; Jantova et al., 2003; Serafim et al., 2008; 
Piyanuch et al., 2007; Katiyar et al., 2009; Lin et al., 2004; Lee et al., 2006; Liu et al., 2005; Kim 
et al., 2004).  Current studies broadly indicate the involvement of cell cytotoxicity, cell cycle 
regulatory machinery, inflammation and cell death signalling pathways as targets of 
anticancer by berberine and Huanglian. It was demonstrated that CR extract can inhibit 
cancer cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase 
activity in human cancer cells and induce apoptosis by up-regulation of interferon-beta and 
TNF-alpha (Low et al., 2002; Li et al., 2000; Kang et al., 2005). Multiple mechanisms 
underlying the anti-cancer action of CR and berberine have been reported and may involved 
inhibition of NFkappa-b pathways, induction of cell cycle arrest and apoptosis (Pandey et 
al., 2008; Hsu et al., 2007; Mantena et al., 2006). Anti-metastatic effects of berberine have 
been reported and inhibition of urokinase-plasminogen activator and matrix 
metalloproteinase-2 was implicated (Peng et al., 2006). It was also reported that berberine 
inhibits HIF-1alpha expression via enhanced proteolysis (Lin et al., 2004). Anti-inflammation 
may be another profile of CR and berberine in treatment of Cancers. The anti-inflammatory 
efficacy of berberine is due to its inhibition of prostaglandin E2 (PGE2) followed by the 
reduction of COX-2 protein in vivo and in vitro of malignant tumor (Kuo et al., 2004). 
Berberine could suppress inflammatory agents-induced interleukin-1ǃ (IL-1ǃ) and Tumor 
necrosis factor-ǂ (TNF-ǂ) productions via inhibiting the phosphorylation and degradation 
of inhibitor of kappa B-ǂ (IκB-ǂ) (Lee et al., 2007). We provide a new mechanism for anti-
invasion of berberine which is to inhibit RhoA signaling pathway, an upstream of NF- 
kappa B (Tsang et al., 2009). In this study, we found that berberine distribution in cell 
nuclear and cytoplasm in dose dependent manner, so anti-invasion of berberine may inhibit 
RhoA signaling pathway at low dose while apoptosis are induced by berberine via G2 arrest 
at high dose in NPC cell lines. Furthermore, at low dose, we use liver cancer cell lines 
(MHCC97-L) to demonstrate that CR extract has better anti-invasion than berberine and 
clarify that anti-invasive effect of CR extract on MHCC97-L cell line specific acts on F-actin 
via Rho/ROCK signaling pathway, but not other metastasis-related molecules such as 
integrin beta4, E-cadherine, u-PA and MMPs (Wang et al., 2010). At high dose, we use liver 
cancer cell lines (MHCC97-L and HepG2) to demonstrate that berberine can induce both 
apoptotic and autophagic cell death, in which apoptosis is major cell death type (Wang et 
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al., 2010). Our results suggests that CR and berberine are promise alternative therapy in 
treatment of cancers.  Computer–aided molecular design and prediction of cell response to 
CR, berberine and analogs, and genomics and proteomics, microRNA approaches to study 
antineoplastic effects of berberine and Huanglian are expected in the future. The relatively 
low toxicities at therapeutic level for both Huanglian and berberine also show additional 
benefit for their further development.  
Adverse responses of berberine include constipation, laxative, anaphylaxis and other 
skin allergies such as dermatitis and rashes, and overdose may cause respiratory and 
circulatory system problems (Bao, 1983). Furthermore, berberine could displace bilirubin 
from serum-binding proteins, causing jaundice, kernicterus, and brain damage in infants 
(Bateman et al., 1998; Chan, 1993, 1994). 
4.2 Arsenic (Pishuang in Chinese) 
In Chinese medicine, arsenic was first recorded in Chinese book “KAI BAO BAN CAO” (Kai 
Bao of Materia Nedica, 973 A.D.).  Arsenic has various forms. The most important 
compounds of arsenic are arsenic trioxide, As2O3, ("white arsenic"), the yellow sulfide 
orpiment (As2S3) and red realgar (As2S2). In 2006 and 2007, China was the top producer of 
arsenic trioxide with almost 50% world share, followed by Chile, Morocco and Peru, reports 
the United States Geological Survey [U.S. Geological Survey, 2008]. In modern society, 
arsenic and its compounds are used as pesticides, herbicides, insecticides and in various 
alloys, while arsenic compounds used as anti-cancer agents are a fascinating story. Arsenic 
has a long history of use in Chinese and Western medicine for cancer treatment. 
Contemporary clinical use of arsenic trioxide is largely due  to purification of this 
compound from traditional mixtures, and the definition of effective, low-dose regimens for 
the treatment of acute promyelocytic leukemia (APL) [Chen et al., 2002]. 
In the 90’s years of last century, two arsenic components including arsenic trioxide (As203) 
[Sun et al., 1992] and arsenic disulfide [Huang et al., 1995] used in some traditional Chinese 
formulae have been shown very effective in patients with acute promyelocytic leukemia 
(APL) treatment. Using NB4 cells model, cellular and molecular mechanisms of arsenic 
trioxide treatment have been clarified by modulation of bcl-2, as well as PML-RAR alpha 
and/ or PML proteins and induction of apoptosis, which is  independent from the retinoid 
pathway [Chen et al., 1996]. Further studies indicated that As2O3 had dose-dependent dual 
effects on APL cells: inducing preferentially apoptosis at relatively high concentrations (0.5 
to 2 micromol/L) and inducing partial differentiation at low concentrations (0.1 to 0.5 
micromol/L) [Chen, et al., 1997], and As2O3 treatment is also an effective and relatively safe 
drug in APL patients refractory to all-trans retinoic acid (ATRA) and conventional 
chemotherapy [Shen et al., 1997]. Differentiation and apoptosis induction therapy in APL 
was established by combination therapy of ATRA and As2O3 [Giannì et al., 1998; Wang et 
al., 2000]. Synergic effects of arsenic trioxide and other drugs on APL, chronic myeloid 
leukemia and other solid cancers, such as in patients with primary hepatocellular and 
gallbladder tumors were also recommended [Chen et al., 2002; Du et al., 2006; Wang et al., 
2008; Hu et al., 2009]. PML and PML-RARalpha (a fusion protein containing sequences from 
the PML zinc finger protein and retinoic acid receptor alpha) degradation is triggered by 
their SUMOylation, but the mechanism by which arsenic trioxide induces this 
posttranslational modification is unclear. Recently, Chen’s group reported in Science 
demonstrated that PML is a direct target of arsenic trioxide providing new insights into the 
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drug’s mechanism of action and its specificity for APL. They showed that arsenic binds 
directly to cysteine residues in zinc fingers located within the RBCC domain of PML-RAR 
and PML. Arsenic binding induces PML oligomerization, which increases its interaction 
with the small ubiquitin-like protein modifier (SUMO)–conjugating enzyme UBC9, resulting 
in enhanced SUMOylation and degradation [Zhang et al., 2010].  
Arsenic and many of its compounds are potent poisons. The International Agency for 
Research on Cancer (IARC) recognizes arsenic and arsenic compounds as group 1 
carcinogens, as their toxic mechanisms, arsenic disrupts ATP production through several 
pathways [Klaassen C, Watkins J. 2003]. 
Arsenic is known to cause arsenicosis owing to its manifestation in drinking water. The 
study of chemolithoautotrophic As(III) oxidizers and the heterotrophic As(V) reducers can 
help the understanding of the oxidation and/or reduction of arsenic [Croal et al., 2004]. 
Treatment of chronic arsenic poisoning has been accomplished [The Psychiatric, 
Psychogenic and Somatopsychic Disorders Handbook. 1978].  
4.3 Rhizoma Curcumae longae (Jiang Huang in Chinese) 
Rhizoma Curcumae longae is the dried rhizome of Curcuma longa L. (Zingiberaceae), 
mainly produced in Sichuan, Fujian, Jiangxi and Yunnan. It was first recorded in Xin Xiu 
Ben cao (659 A.D.). The rhizome is collected in autumn and winter when the aerial part 
wither, washed clean, boiled or steamed thoroughly, dried in the sun, removed from fibrous 
root, and cut into slices. Traditionally, Rhizoma Curcumae longae can be used in treatment 
of pains and tumour induced by Qi and blood stasis. 
Major chemical components in Rhizoma Curcumae longae are volatile oil (6%) composed of 
a number of monoterpenes and sesquiterpenes, including zingiberene, curcumene, ǂ- and ǃ- 
turmerone and others. The colouring principles (5%) are curcuminoids, 50–60% of which are 
a mixture of curcumin, monodesmethoxycurcumin and bisdesmethoxycurcumin (WHO 
Monographs on Selected Medicinal Plants). Recent pharmacological studies show that 
Rhizoma Curcumae longae has various kinds of action, including anti-inflammation, anti-
microbial, anti-oxidation, cholagogue, antihyperlipidemics and cardiovasucular action. 
There has been a long history for studies focusing on anti-tumor effect of Rhizoma 
Curcumae longae since Kuttan and his collegues firstly reported its anti-cancer potential in 
1985 (Kuttan et al., 1985). Recent study reveals the anti-tumor activity of radix curcumae 
extract on human cervical cancer cells in vitro and in vivo by inducing, G1 cycle arrest, 
apoptosis and inhibiting proliferation. Molecular events invovled include retinoblastoma 
protein dephosphorylation, reduced amounts of cyclins D1 and D3, and cyclin-dependent 
kinase 4 and 6 proteins, caspase activation and PARP cleavage, mitochondrial membrane 
potential loss by Mcl-1 and Bcl-xL reduction and reduced PTEN, AKT, and STAT3 
phosphorylation and downregulation of NFkappaB signaling (Lim et al., 2010). The anti-
carcinogenic effect of Curcuma longa was further domonstrated in MNNG-induced 
tumorogenesis model, where the herbal extract reduces the expressions of VEGF, COX-2 
and PCNA and inhibits gastric cancer growth (Lu, et al., 2010). Moreover, recent study 
exhibits the immunostimulatory activities of polysaccharide extract of Curcuma longa, 
indicating its potential as an adjuvant supplement for cancer patients, whose immune 
activities were suppressed during chemotherapies (Yue et al., 2010). As the major active 
compound discovered in Curcuma longa, curcumin is also under extensive study on its anti-
tumor activity and underlying mechanism. Sahu et al reported that curcumin is able to 
induce G2/M cell cycle arrest in human pancreatic cancer cells. Phosphorylation of Chk1 at 
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Ser-345, Cdc25C at Ser-216 and a subtle increase in ATM phosphorylation at Ser-1981 are 
observed and silencing the Chk1/ATM pathway attenuated curcumin’s effect on cancer cell 
cycle (Sahu et al., 2009). Another study also exhibits curcumin’s action on G1/S phase of cell 
cycle in human prostate cancer cells, whcih is correlated with curcumin-induced expression of 
cyclin-dependent kinase (CDK) inhibitors p16(/INK4a), p21(/WAF1/CIP1) and p27(/KIP1), 
and the suppression of cyclin E and cyclin D1, and hyperphosphorylation of retinoblastoma 
(Rb) protein (Srivastava, et al., 2007). Curcumin could also depolymerizes mitotic 
microtubules, perturbes microtubule-kinetochore attachment and disturbes the mitotic spindle 
structure. Pertubed localization of the kinesin protein Eg5 and subsequent monopolar spindle 
formation is induced by curcumin. Further, curcumin increases the accumulation of Mad2 and 
BubR1 at the kinetochores and activate the mitotic checkpoint to induce apoptosis (Banerjee et 
al., 2010). Curcumin is able to induce apoptosis by some other pathways. Chen et al shows that 
curcumin could activate Bax expression and suppress Bcl-2 to change the Bax/Bcl-2 ratio, and 
decrease the motochondrial membrane potential to led to Cytochrome C release, caspase-9 and 
-3 activation and PARP cleavage. Blockade of caspase pathway attenuates curcumin’s effect on 
apoptosis induction in human A549 lung adenocarcinoma cells (Chen et al., 2010). Curcumin 
also induces apoptosis through activate FAS and FADD, and triggers caspase-3 independent 
apoptotic cell death (Lu et al., 2009). Moreover, Curcumin was reported to inhibit tumor 
growth through some other different pathways. Choi et al states that curcumin interrupts the 
interaction between the androgen receptor and Wnt/beta-catenin signaling pathway in 
LNCaP prostate cancer cells by suppressing the beta-catenin expression, and therefore inhibits 
the prostate tumor grwoth (Choi et al., 2010). Another study reveals that curcumin’s inhibitory 
effect of tumor growth is correlated with Sp transcrption factor-regulated decreased 
expression of NF-kappaB and its downstream genes such as cyclin D1, survivin, and vascular 
endothelial growth factor that contribute to the cancer phenotype (Jutorru et al., 2010). Ning et 
al reports that curcumin is able to down-regulate the Notch1 Intracellular Domain and inhibits 
the Notch1 signaling, which is correlated with the induction of cleaved poly ADP-ribose 
polymerase (PARP), the degradation of cyclin D1 and increase in cyclin-dependent kinase p21. 
This notch1 inhibtion contributes to curcumin’s inhibitory effect on hepatocellular carcinoma 
growth (Ning et al., 2010).  
Oxdiative stress is also involve as an important mechanism of curcumin’s anti-tumor effect. 
Curcumin could potentiate paraptosis in human breast cancer cells by promoting 
vacuolation from swelling and fusion of mitochondria and/or the endoplasmic reticulum 
(ER). The paratosis inhibitor AIP-1/Alix protein was downregulated by curcumin, and AIP-
1/Alix overexpression attenuated curcumin-induced death in these cells (Yoon et al., 2010). 
Reactive oxygen species induced by curcumin in human non-small cell lung cancer cell 
triggers Bcl-2 protein’s degrdation, and sensitizes cells to detachment-induced anoikis 
(Pongrakhananon et al., 2010). However, curcumin was also reported to be an anti-tumor 
agent in oxidation-resistant cells, and gamma- glutamyltranspeptidase inhibition play the 
major role in curcumin’s effect (Quiroga et al., 2010). In addition, curcumin is also reported 
to induce an apoptosis-independent cell death in human cancer cells (O'Sullivan-Coyne et 
al., 2009). Moreover, curcumin exhibits its anti-migration action on nasopharyngeal 
carcinoma cells through up-regulation of E-cadherin, indicating its potential as an anti-
metastasis agent (Wong et al., 2010).  
As a novel molecular event in cancer progress, microRNA has been demonstrated for its 
important role in regulating human tumoriogenesis. Curcumin was also reported to target 
to miRNA to exert its anti-tumor activity. Zhang et al reports that curcumin down-regulates 
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the expression of miR-186* in and overexpression of miR-186* significantly inhibited 
curcumin-induced apoptosis in A549/DDP cells (Zhang et al., 2010). Curcumin could also 
alter miRNA expression in human pancreatic cells, up-regulating miRNA-22 and down-
regulating miRNA-199a*, and up-regulation of miRNA-22 expression by curcumin in 
pancreatic cancer cells suppresses expression of its target genes SP1 transcription factor 
(SP1) and estrogen receptor 1 (ESR1), which may be correlated with curcumin’s anti-cancer 
activity (Sun et al., 2008).  
Similar to the crude extract, curcumin exhibits immunomodulatory property in suppressing 
the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-
protein kinase Cdelta-STAT1 signaling pathway, and showed its potential as an adjuvant 
agent in cancer chemotherapy (Jeong et al., 2009) 
4.4 Radix stephaniae tetrandrae (Han Fangji in Chinese) 
Radix stephaniae tetrandrae is the dried root of Stephania tetrandra S. Moore 
(Menispermaceae). With its Chinese name as Han Fangji, it was firstly recorded in Shennong 
Bencao Jing. Commonly called as Stephania root or Tetrandra root, the Radix stephaniae 
tetrandrae is considered to be bitter, cold and pungent, and belongs to the meridians of 
Urinary bladder, kidney and spleen. Han Fangji is distributed in Shanxi, Yunnan and 
Guangxi Province of China. It is used to dispel wind and dampness, and to relieve edema 
and pain in Chinese Medicine clinical practice.  
The phytochemical study on Radix stephaniae tetrandrae exhibits that it contains several 
kinds of alkaloids, including Tetrandrine, Fangchinoline, Cyclanoline and Trilobine. Recent 
pharmacological studies show that Radix stephaniae tetrandrae and its compounds has anti-
inflammatory (Shen et al., 2001), antihypertensive, anti-arrhythmic (Yu et al., 2004), and 
cardiovascular action (Wong et al., 2000). 
The whole extract or chemical fraction of Radix stephaniae tetrandrae was rarely reported 
for its anti-tumor activity either in vitro or in vivo. The reason behind may be that one of 
other plants, Aristolochia fangchi, was used as an substitution of Stephania tetrandra due to 
their similar name in Chinese (Guang Fangji for Aristolochia fangchi and Han Fangji for 
Stephania tetrandra). Several years ago, several studies reported that urothelial carcinoma is 
associated with the use of Aristolochia fangchi, which contains nephrotoxic and 
carcinogenic aristolochic acids, to replace Stephania tetrandra (Nortier et al., 2000). 
However, a recent report that a Stephania tetrandra-containing Chinese Herb Formula, 
SENL, could reduce the expression of mutildrug resistance- associated protein and increase 
the intracellular accumulation of chemotherapeutic agent, Adriamycin, in human lung 
cancer cell line SW1573/2R120 (Xu et al., 2010), indicating Stephania tetrandra could be used 
as a complementary agent in chemotherapy to enhancing cancer cell sensitivity to 
chemotherapeutic agents. In contrast, as the major compound isolated from Stephania 
tetrandra, tetrandrine is extensively reported for its anti-tumor activity in various human 
cancers. Tetrandrine induces human cancer cell cycle arrest at G1 by first, inhibiting cyclin-
dependent kinase 2 (CDK2)/cyclin E and CDK4 and second, inducing the proteolysis of 
CDK4, CDK6, cyclin D1, and E2F1 in HT-29 cells (Meng et al., 2004). Consistent observation 
of G1 arrest action of tetrandrine could be also found in another study and may be 
attributable to tetrandrine’s inhibitory effect on AKT pathway. Inhibition of Akt could 
subsequently activate GSK3ǃ and upregulate p27 (Chen et al., 2008). Tetrandrine was also 
reported to be capable of inducing cell apoptosis in various kinds of human cancers, 
including lung carcinoma (Lee, et al., 2002), leukemia (Jang et al., 2004), hepatoma (Ng et al., 
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2006), nasopharyngeal carcinoma (Sun et al., 2006) and colon cancer (Chen et al., 2008). Jang 
et al. stated that tetradrine could induce early oxidative stress and produce ROS in human 
U937 cells and this result in activation of JNK pathway. However, the activation of JNK is 
not responsible for tetrandrine-induced apoptosis but caspase-dependent generation of a 
catalytically active fragment of PKC-delta may play a role (Jang et al., 2004). Sun et al. 
reported that tetradrine is able to induced apoptosis in human nasopharyngeal carcinoma 
cells CNE and this effect results from the increased expression of pro-apoptotic Bax mRNA 
transcript and decreased expression of anti-apoptotic factor Bcl-2 mRNA transcript (Sun et 
al., 2006). Wu et al. showed that apoptosis could be induced by tetrandrine in colon cancers 
and the increased expression of Erk1/2 and p38 MAPK are observed. However, only p38 
MAPK is responsible for tetrandrine-induced apoptosis in CT-26 cells (Wu et al., 2010). 
However, Cho et al. stated that tetrandrine selectively inhibits the proliferation of lung 
cancer cells by blocking Akt activation and increases apoptosis by inhibiting ERK in human 
lung carcinoma cellA549 (Cho et al., 2009). These studies indicate the multiple targets of 
tetrandrine in treating human cancers. In addition, tetrandrine was reported to inhibit 
gliomas angiogenesis by suppressing the VEGF expression in gliomas cells (Chen et al., 
2004) and suppress pulmonary metastases of colorectal adenocarcinoma (Chang et al., 2004), 
where F-actin and microtubule remodeling may be involved (Lee et al., 2002). Moreover, 
tetrandrine was extensively reported for its capacity in reducing multidrug resistance 
(MDR) by inhibiting MDR-related protein P-gp at either expression or enzymatic level and 
increasing the efficacy of chemotherapeutic agent (Shen et al., 2010). However, it is 
contradictory to observe no significant difference between the doxorubicin pharmacokinetic 
parameters obtained in mice received doxorubicin only and doxorubicin combined with 
tetrandrine (Dai et al., 2007). Further study may be required to assure the exact action and 
mechanism of tetrandrine in helping chemotherapeutic agents to overcome the MDR in 
human cancer. Another major compound in Radix stephaniae tetrandrae, fangchinoline, also 
exhibits reversal effect on the MDR of cancer cells in response to chemotherapeutic agents 
paclitaxel and vinblastin via modulation of P-gp (Chio et al., 1998; Wang et al., 2005), 
however, very few studies were focusing on its anti-tumor mechanism. A recent 
investigation reports that fangchinoline could induce G1/S phase cycle arrest via inhibiting 
Cyclin D1 and overexpressing p27 in human prostate cancer cell PC3. In addition, 
fangchinline is able to potentiate cancer cell apoptosis by inducing pro-apoptotic Bax and 
down-regulating anti-apoptotic Bcl-2. Inhibition of prostate cancer in xenograft model by 
fangchinline was also observed (Wang et al., 2010). Our on-going study shows that 
fangchinoline could not induce apoptosis in human hepatocellular carcinoma cells though 
the potent cell death could be observed when exposed to low dose of fangchinoline, 
indicating an althernative cell death model may be involved in fangchinoline’s effect. We 
found that autophagic cell death may be the substitute and activation of AMPK signaling 
may play a role. 
There is no report on the adverse reaction of Radix stephaniae tetrandrae, but overdose of 
Radix stephaniae tetrandrae (4.5-9 grams in decoction is appropriate) may induce vomiting, 
tremor, ataxia, convulsions, quadriplegia, hypertonicity, and respiratory failure. 
4.5 Radix tripterygii wilfordii (Lei Gongteng in Chinese) 
Radix Tripteryii Wilfordii is the dried root of Triptrygium Wifordii Hook F. It is a native 
plant that grows widely in China, distributed in Zhejiang, Anhui, Jiangxi, Hu’nan, 
Guangdong, Guangxi, Fujian, Taiwan and Yunnan province. It is used to dispel wind and 
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dampness, and to relieve arthritis and pain in Chinese Medicine clinical practice. Anticancer 
application is a new use for Radix tripterygii wilfordii. 
The phytochemical study on Radix tripterygii wilfordii indicates that it contains various 
kinds of alkaloids, including wilfordine, wilforine, wilforidine, wilforgine, wilfortrine, 
wilforzine, wilformine, wilfornine, euonine, celacinnine, celafurine, celabenzine, 
neowilforine, regilidine and terpenoids, including triptolide T13, tripdiolide, tripterolide, 
triptonide, triptolidenol T9, hypolide, triptonoterpenol, triptophenolide methylether, 
neotriptophenolide, isotriptophenolide, isoneotriptophenolide, triptonoterpene, 
triptonoterpene methylether, tripdioltonide, tripdiolide T8, triptriolide T11, triptolide T10, 
wilforlide AT1, triptotriterpenoidal lactone A, wilforlide B, triptotriterpenic acid AT3, 
triptotriterpenic acid BT2, triptoterpenic acid CT28, selaspermic acid, wilfornide, 
triptofordin A,B,C-1,C-2, D (Xian et al., 1997).  
Tripteryii Wilfordii was traditionally used as an important medicine for thousand of years 
in Chinese Medicine to treat the syndrome associated with immune- inflammatory diseases 
(Jia, 1985). However, it has been shown to have multiple uses in Chinese medicine of not 
only immune-inflammatory diseases, but also cancers, neurodegenerative diseases and 
fertility regulation (Brinker et al., 2007). 
Triptolide is the predominant bioacitive compound which is isolated from Radix Tripterygii 
wilfordii (Zhou et al., 2010). A lot of studies show that triptolide has the anti-cancer effect by 
inducing cell apoptosis in several kinds of cancers, including leukemia (Lou et al., 2004), 
colorectal cancer (Min, 2010; Xu et al., 2010), Cholangiocarcinoma (Clawon et al., 2010; Lou 
et al., 2004), pancreatic cancer (Chen et al., 2010; Chang et al., 2010) and breast cancer (Liu et 
al., 2009). The latest research showed that triptolide has the anti-cancer effect via inducing 
cell death in pancreatic cancer cells via autophagy and apoptosis (Mujumdar et al., 2010). 
Mujumdar et al. reported that triptolide could induce autophagy by some specific genes, 
atg5 or beclin 1. Some studies indicate that triptolide inactivated the Protein kinase B (Akt)/ 
mammalian target of Rapamycin/ p70S6K pathway and up-regulated the expression of 
Extracelluar Signal-Related kinase (ERK) 1/2 pathway to promote apoptosis in pancreatic 
cancer cell lines (Mujumdar et al., 2010). Wang et al. showed that triptolide has the anti-
cancer effect on acute myeloid leukemia by causing down-regulation of C-KIT and 
inhibiting the JAK-STAT signaling, which is the same as the situation in colon cancer (Wang 
et al., 2009). Moreover, the expression of p65 was decreased by triptolide, which inhibits the 
DNA-binding activity of NF-kappaB. Triptolide also has been shown to have the ability of 
decreasing cell viability in all cell lines at 48h via activating caspase-3 (Clawon et al., 2010). 
In endometrial and ovarian cancer cells, triptolide has been reported to have the anti-growth 
activity via targeting some specific genes, such as LRAP, CDH4, SFRP1 and so on (Li et al., 
2010). Besides, some studies indicate that triptolide could act as the inhibitor of RNA 
polymerase I and II-dependent transcription promoting some short-lived mRNA, for 
example cell cycle regulator CDC25A (Vispé et al., 2009). 
Celastrol is another main component isolated from radix tripterygii wilfordii, which has 
been reported to have the anti-cancer effect in cancer cell lines including leukemia (Lu et al., 
2010), glioma (Zhou et al., 2009) and so on. Lu et al. reported that celastrol could decrease 
the protein levels of Bcr-Abi and inhibit the growth in chronic myelogenous leukemia (Lu et 
al., 2010). Zhou et al. showed that celastrol has the anti-angiogenic effect in human glioma 
via in vitro and in vivo study (Zhou et al., 2009). The other studies denoted that celastrol 
could suppress the tumor growth mediated by angiogenesis by inhibiting AKT pathway 
(Pang et al., 2010). 
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The side effects of tripterygii wilfordii include gastrointestinal upset, infertility and 
suppression of lymphocyte proliferation (Chou et al., 1995). 
4.6 Radix scutellariae (Huangqin in Chinese) 
Radix scutellariae with the Chinese name of Huangqin, is the root of Scutellaria baicalensis 
Georgi (Labiatae). It is native to Jilin, Liaoning, Shanxi, Henan, Inner Mongolia and Hebei 
Province of China. Radix scutellariae can be obtained from wild or cultivated species. Roots 
of the herbs are dried for medical use. Fruits are also collected and used as herbal drugs. It 
can be used in treatment of symptomes induced by damp-heat or heat-toxicity which can be 
convinced to be diseases related to infection or inflammation in Chinese medicine clinical 
practice. 
Radix scutellariae includes a series of flavones and their derivatives, such as baicalein, 
baicalin, chrysin, 5,6-dihydroxy-7-O-glucoside-flavone, 5,7,2'-trihydroxy-flavone, 5,7,2', 3'-
tetraflavone,  5,7,2',6'- tetraflavone, 5,7,2'-trihydroxy-8-methoxyflavone, oroxylin-A-
glucoronide, oroxylin-A, 5,7,2'-trihydroxy- 6-methoxyflavone, nor-wogonin, Wogonin, 
Wogonoside, 5,8,2'-trihydroxy-7-methoxyflavone, Wogonoside, Scutevulin, etc. Other 
chemicals in Huangqin include proline, acetophenone, palmitic acid, etc. According to 
China Pharmacopeia (Edition 2005), baicalin is used as quality criteria for raw Radix 
scutellariae, and the content of bacalin should not be lower than 9.0% for the raw material.  
It was reported that the stem and leaves of Radix scutellariae reveals potent anti-bacterial 
effect in vitro study (Zhao et al., 2007). Some studies indicated that the ethyl acetate 
extracting fraction showed the best anti-bacterial effect among fractions isolated from Radix 
scutellaria (Ren et al., 2005). Total flavones from stem and leaf of Radix scutellaria showed 
preventive effect against experimental hyperlipidemia (Yi et al., 2005).  
Modern studies denoted that Radix scutellaria has anti-cancer effect in various kinds of 
cancer cell lines including breast cancer cell (Zhou et al., 2009; Wang et al., 2010), lung 
cancer (Gao et al., 2010), leukemia (Kumagai et al., 2007), prostate cancer (Miocinovic et al., 
2005) and so on. 
It was reported that anti-proliferative and apoptotic activity against acute lymphocytic 
leukemia, lymphoma and myeloma cell lines (Kumagai et al., 2007). The predominant of the 
anti-cancer effect of baicalin has been shown to induce apoptosis (Lian et al., 2003). The 
investigation of baicalin showed that it could induce prostate cancer cell line DU 145 
apoptosis in vitro via inhibiting Bcl-2 and Bax while up-regulating Fas (Gu et al., 2005). 
Wang et al. reported that baicalin induced breast cancer cells apoptosis by increasing the 
expression of p53 and Bax (Wang et al., 2008). Besides, some studies indicated that the 
cancer cell death and proliferation retardation may be induced by the inhibition of CDC2 
kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase 
and AKT (Chao et al., 2007). Moerover, Sun et al. showed that baicalin played the role of 
suppressing MDA-MB-435 human breast cancer cells invasion by decreasing matrix 
metalloproteinase-2/9 (Sun et al., 2009). 
Another active compound, wogonin, has also been reported to induce apoptosis in cancer 
cell lines (Li, 2010). Lee et al. showed that wogonin could involve in the regulation of 
apoptosis in human cancer cells which may associate with p53, PUMA, and Bax (Lee et al., 
2008). Zhao et al. also reported that wogonin exert anti-cancer effect via decreasing the 
expression of NF-KappaB which induced apoptosis (Zhao et al., 2010). Besides, wogonin has 
been shown to delay cancer cell growth through inhibiting Akt, GSK-3 and NF-KappaB 
signaling (Parajuli et al., 2010). 
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Clinical adverse reactions include: gastric discomfort and diarrhea; fever reaction after i.v. 
injection of baicalin at dose of 150 mg (Bi, 1998; Nemoto et al., 2002) 
4.7 Herba artemisiae annuae (Qinghao in Chinese) 
Qinghao is the aerial part of Artemisia annua L. (Compositae). It is native to Hebei, 
Shandong, Jiangsu, Hubei and Fujian Province of China. Qinghao can be obtained from wild 
or cultivated species. It is used for fever and antimalaria in Chinese medicine clinical 
practice. 
Artemisinin, artemisinin I, artemisinin II, artemisinin III, artemisinin IV, artemisinin V 
arteannuic acid, aremisilactone and artenimol and their derivations are the main 
composition of raw material of Qinghao. The major pharmacological action of Qinghao 
includes antimalaria, antiviral, treatment of schistosomiasis and anticancer activity (Feng et 
al., 2010). 
A systematic screening on the active components in Herba artemisiae annuae with 
cytotoxicity on serveral human tumor cell lines was investigated in 1994, which then started 
the cellular and molecular mechanism study of the anti-tumor activity of compounds from 
Herba artemisiae annuae. Artemisinin and quercetagetin 6,7,3′,4′-tetramethyl ether showed 
significant cy-totoxicity against P-388, A-549, HT-29, MCF-7, and KB tumor cells in this 
study (Zheng, 1994). As the major component in Herba artemisiae annuae, artemisinin and 
its derivatives were extensively reported for their anti-tumor action and underlying 
mechanism. The general mechanism of the anti-tumor activity of artemisinin and its 
derivatives may be that artemisinin-like chemical could carry iron, which is required for the 
proliferation of cancer cells, and form free radicals to kill the cancer cell (Lai et al., 2005). 
However, there are some other particular mechanisms invovled. Artemisinin is able to 
induce G1 arrest of the cell cycle in human hepatoma cells via regulating cyclin D1, CDK2, 
CDK4 and serveral other CDK inhibitos (Hou, et al., 2008). Mechanism study shows that 
artemisinin could disrupt the interaction of transcription factor Sp1 and CDK4 promoter 
and therefore suppress the expression of CDK4 (Willoughby, et al., 2009). Artemisinin is 
able to induce apoptosis with a caspase-3 dependent manner in cancer cells (Nam et al., 
2007), and could selectively decrease functional levels of estrogen receptor-alpha to suppress 
the proliferation of human breast cancer cells (Sundar et al., 2008). In addition, Artemisinin 
could reduce cell migration in human melonoma by suppressing alpha V beta 3 integrin and 
reducing metalloproteinase 2 production (Buommino, et al., 2009).  
Another major compound is dihydroartemisnin. A study reported that dihydroartemisinin 
is able to induce G1 cell cycle arrest in human pancrate carcinoma cells though regulating 
cyclin E, cdk2, cdk4 and p27(Kip1) (Chen et al., 2010). Dihydroartemisinin induces apoptosis 
through potentiating the mitochondrial transmembrane permeability, releasing cytochrome 
c and activating of caspases (Lu, et al., 2009). The induction of apoptosis by 
dihydroartemisinin is Bak- or NOXA-dependent (Handrick et al., 2010). Another study 
reports that the anti-cancer activity of dihydroartemisinin is associated with induction of 
iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells (Lu, et 
al., 2010). In human prostate carcinoma cells, dihydroartemisinin was observed to induce 
tumor cell death via extrinsic and intrinsic pathway. Transcriptional activation of the death 
receptor 5 (DR5) and suppression of PI3-K/Akt and ERK cell survival pathways may play a 
role (He et al., 2010). Studies also reveal that dihydroartemisnin exhibits anti-migration 
effect on human fibrosarcoma cell HT-1080 through inhibition of PKCalpha/Raf/MAPKs 
and NF-kappaB/AP-1-dependent mechanisms (Hwang, et al., 2010). In addition, 
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dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in 
vivo, where dihydroartemisinin could help inhibit tumor growth through inducing 
apoptosis and suppress metastasis via down-regulating the expression of VEGF receptor 
KDR/flk-1 (Zhou, et al., 2010). To further expolre the active compounds in Herba artemisiae 
annuae, a study was carried out to compare the anti-tumor effect of compounds in Herba 
artemisiae annuae on chemoresistant cancer cells, and found artesunate being the most 
active (Michaelis et al., 2010). Artesunate was reported to induce DNA damage (Li, et al., 
2008) and apoptosis (Michaelis et al., 2010) in cancer cells. Recently, an interesting 
investigation reported a caspase-independent mechanism of cell death induced by 
artesunate, an oncosis-like cell death in pancrate cancer cells. This kind of cell death is 
dependent on the loss of mitochondrial membrane potential and the presence of reactive 
oxygen species (ROS) (Du et al., 2010). Moreover, artesunate exhibits anti-angiogenic effect 
in human ovarian cancer through inhibiting the VEGF receptor KDR/flk-1 expression (Chen 
et al., 2004). Finally, recent study shows that the old member of the artemisinin derivates 
artemisone also exhibits significant anti-tumor effect (Gravett et al., 2010). These extensive 
studies reveal the potential of compounds from Herba artemisiae annuae for anti-cancer 
therapy in clinical practice. 
4.8 Radix Ginseng (Renshen in Chinese) 
Radix Ginseng, the dried root of Panax ginseng C.A. Meyer (Araliaceae), has been widely 
used as a tonic agent in traditional Chinese medicine for improvement in physical and 
mental capacities. The earliest written account of Radix Ginseng is from “Shen Nong Ben 
Cao Jing” (Shen Nong’s Materia Medica, circa A.D. 100). Its species include Radix ginseng 
cruda, Radix ginseng rubra and Radix ginseng silvestris, and is mainly produced in Jilin, 
Liaoning, Heilongjiang Provinces of China and Korea. Wild ginseng is called “Shanshen”, 
whereas the cultivated ones are known as “Yuanshen” (Garden Ginseng), of which, the sun-
dried or bake-dried are called “Shengshaishen” (Sun-dried Ginseng). The fresh ginseng, 
which is made by steaming and then drying under the sun or heat, is called “Red Ginseng” 
(Radix ginseng rubra). The sun-dried and freezing-dried wild ginseng is named “Sun-dried 
Wild Ginseng” [Pharmacopoeia of the People’s Republic of China, 2000].  
Numerous constituents of radix ginseng such as ginsenosides (ginseng saponins), 
polysaccharides, peptides, polyacetylenic alcohols, aminoglycosides, and ginseng oils have 
been found and characterized. Among these, ginsenosides are believed to be the main active 
constituents in the pharmacological actions of ginseng. Ginsenosides are triterpenoid 
glycosides of dammarane and oleanane structures and so far more than 30 ginsenosides 
have been isolated from radix ginseng. According to the chemical structure characteristics, 
ginsenosides can be divided into three groups: panaxadiol, panaxatriol and oleanolic acid 
[Chang et al., 1992]. 
There is an increasing interest in radix ginseng regarding the human cancers. It is believed 
that the life-prolonging effect of radix ginseng may be because of the protective effect 
against various cancers such as prostate cancer, ovarian cancer and lung adenocarcinoma 
[Kim et al., 2004; Liu et al., 2000; Nakata et al., 1989]. Ginsenosides are the major antitumor 
constituents in radix ginseng. In a recent study in Korea, ginsenoside Rp1 was examined the 
anti-metastatic activities using in vitro assays and in vivo metastasis models [Tae et al., 
2008]. This study suggested that ginsenoside Rp1 might act as an anti-cancer agent by 
strongly inhibiting cell viability and metastatic processes, presumably by inhibiting the 
adhesion of tumor cells and vessel formation. Another study in Hong Kong indicated that 
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ginsenosides might act in a similar way as steroid hormones attributes to the effect in anti-
cancer. The study found that ginsenosides can act as functional ligands to activate different 
steroid hormone receptors [Yue et al., 2007]. The results of the study showed that the anti-
tumour effects of ginsenosides included its ability to induce cell death (such as apoptosis 
and necrosis), and having effects of anti-proliferation, anti-invasion and metastasis, and 
anti-angiogenesis. Moreover, ginseng has been found to be a therapeutic agent for renal cell 
carcinoma (RCC) [Jeongwon et al., 1998], a disease which many patients having been 
diagnosed to be in metastatic status at initial diagnosis [Lam et al., 2005]. It was suggested 
that lipid soluble components of ginseng inhibit the growth of RCC cell lines by blocking 
cell cycle progression at G1 to S phase transition. Furthermore, ginseng has been established 
as non-organ specific cancer prevention [Yun, 2001]. There was a dose-response relationship 
that was showed between the decreased risk of cancer with increased ginseng intake. 
A “ginseng-abuse syndrome” was reported in 14 of 133 long-term ginseng users [Siegel, 
1979]. These patients experienced hypertension, nervousness, sleep-lessness, skin eruptions 
and diarrhoea; some subjects also became euphoric and agitated. Doses of 15 g were 
associated with depersonalization and confusion, while depression was reported after more 
than 15 g per day. Moreover, estrogenic-like side effect of ginseng had been published 
[Punnone et al., 1978]. Furthermore, it was reported that ginseng might inhibit the effects of 
warfarin [Janetzky, 1997] and interact with the monoamine oxidize inhibitor phenelzine 
[Jones et al., 1987]. 
4.9 Radix notoginseng (Sanqi/Tienchi in Chinese) 
Radix notoginseng is the dried root of Panax notogiseng (Burk.) F. H. Chen (Araliaceae). It 
was first recorded in “Compendium of Materia Medica” (“Bencao Gangmu” in Chinese) by 
Li Shizhen (1518–1593 A.D.). Radix notoginseng has a long history of use as a traditional 
herbal medicine due to its blood circulation promotion, blood stasis removal and pain 
alleviation effects, and has been widely utilized for the prevention and treatment of 
microcirculatory disturbance in Oriental countries [Lee et al., 2009]. The herb is slightly 
bitter in favor, non-toxic and is mainly cultivated in Wenshan region, Yunnan province in 
China.  
Similar to P. ginseng C. A. Meyer and P. quinquefolius L., P. notoginseng contains saponins 
as its main bioactive constituents, commonly referred to as ginsenosides, notoginsenosides 
and gypenosides. Other types of constituents extracted from Radix Notoginseng such as 
essential oils, amino acids, polysaccharides, dencichine and flavonoids are also 
pharmacologically active and have a function on some diseases [Modern Chinese Materia 
Medica, 2007].  
Recently, several studies have demonstrated the inhibitory effects of Radix Notoginseng 
extract against a variety of human cancers, such as skin tumours, cervical cancer, prostate 
cancer, gastric cancer, colorectal cancer, sarcoma and breast cancer [Ng, 2006]. Laboratory 
studies on colorectal cancer suggested that Radix Notoginseng could be used alone or as 
adjuncts to existing chemotherapy to improve the outcomes of the chemotherapeutic 
treatment and reduce the adverse effects of chemotherapy [Wang et al., 2007; Wang et al., 
2009; Sadeghi and Yazdanparast, 2005; Zhang et al., 2007]. These Studies found that the anti-
proliferative activity of Radix Notoginseng extract was most probably because of cell cycle 
arrest, which the cancer cells were arrested in S phase and G2/M phase, and the induction 
of cancer cell apoptosis. Wang’s group also suggested that the anti-proliferative effects of 
Radix Notoginseng were in a concentration-dependent manner. Nowadays, the induction of 
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cancer cell apoptosis, which is a programmed cell death, is an important therapeutic 
mechanism in anti-cancer drug. The mechanism of the induction of apoptosis in human 
cancer cells, such as lung carcinoma cells, cervical cancer cells and gastric cancer cells, by 
Panax Notoginseng extracts (PNE) was investigated in the recent studies. The studies 
showed that PNE treatment significantly inhibited the cell viability and induced cancer cell 
death in a dose-dependent manner. Furthermore, the results of these studies indicated that 
the major regulators of PNE-induced apoptosis in human carcinoma cells are the Bcl-2 
family and caspase-3, which are associated with mitochondrial dysfunction and 
dephosphorylation of the Akt signaling pathway [Park et al., 2009; Yang et al., 2006; Li et al., 
2008]. Except the inhibition of cancer cell proliferation and the induction of apoptosis, the 
regulation of gap junctional intercellular communication (GJIC) was believed to play an 
important role in cancer prevention [ Ruch, 1994]. Recently, a study on human 
hepatocarcinoma cells suggested that Radix Notoginseng saponins could up-regulate or 
recover GJIC function which was in a concentration-dependent manner [Shang et al., 2006].     
Minor allergic effects of Radix Notoginseng were reported in some studies [Yang et al., 
2002]. The allergic reactions were likely due to the low quality of Radix Notoginseng use.  
4.10 Radix Astragali (Huangqi in Chinese) 
Radix Astragali (RA) is derived from the dried roots of Astragalus membranaceus (Fisch.) 
(Leguminosae). Bunge and Astragalus membranaceus (Fisch.) Bunge var. mongholicus 
(Bunge) Hsiao are two commonly used species. RA is mostly prepared from cultivated ones, 
as wild ones are increasingly scarce, mainly produced in the northern part (Shanxi, 
Neimenggu, and Hebei) and the northeastern part (Heilongjiang) of China. Recent studies 
indicated that Shanxi of China produced the best quality of Radix Astragali [Ma et al., 
2000].The earliest scientific description of RA was in Shen Nong Ben Cao Jing, a materia 
medica book edited in the 1st century. It has been traditionally used as a qi-tonifying drug 
or an adaptogenic herb in Chinese medicine for thousands of years. RA is prescribed as an 
immunostimulant, hepatoprotective, anti-perspirant, a diuretic or a tonic, and is used for 
treatment of many diseases in Chinese medicine clinical practice [Sinclair, 1998].  
Regarding the chemical constituents of RA, more than 100 compounds have been isolated 
and identified up to now, and the most often associated with the biological activity of RA 
are isoflavonoids, triterpene saponins, polysaccharides, amino acids, and various trace 
elements [Chen et al., 2008; Gui et al., 2006; Lin et al., 2000]. Among these, astragaloside IV 
(one of the two main saponins), calycosin and formononetin (two of the three major active 
isoflavonoids) are normally being used as makers for RA’s quality control [Song et al., 2004]. 
Sinclair’s study found that RA has a wide range of immunopotentiating effects, and has 
been used extensively as an adjuvant in cancer therapy and as a phytochemical immune 
modulator. A study on the effects of RA extract reported that RA lowered the incidence of 
urinary bladder carcinoma in N-butyl-N’-butanolinitrosoamine treated mice by activating 
the cytotoxicity of lymphocytes and increasing the production of IL-2 and IFN-Ǆ [Kurashige 
et al., 1999]. Another study indicated that RA extract significantly increased the activity of 
IL-2, of B cell growth factor and IL-6 in vitro and of phytoemagglutinin-induced 
proliferation of T lymphocytes from patients with IgG subclass deficiency [Tu et al., 1995]. 
Renal cell carcinoma has been shown to produce factors which may impair the normal 
functions of the immune system, such as macrophage function suppression. A laboratory 
study found evidence that RA restored the chemiluminescent oxidative burst activity of 
murine splenic macrophages which were shown to be suppressed by renal cell carcinoma. It 
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was also suggested that RA might have exerted its anti-tumor effect via augmentation of 
phagocyte and lymphokine-activated NK cell activities in vivo [Lau et al., 1994; Yang et al., 
1998]. Guanine nucleotide exchange factors (GEFs) (oncogenes), such as Vav proteins (Vav1, 
Vav2 and Vav3) are hyperactive in various cancers. A recent study demonstrated that 
Vav3.1 expression was down-regulated by astragaloside IV in a dose- and time-dependent 
manner which might be highly correlated with the inhibition of the cellular malignant 
transformation. Thus, the study suggested that astragaloside IV might elicit anti-cancer 
activity via down-regulating the expression of oncogenes such as Vav3.1 [Qi et al., 2010]. It 
was revealed that RA could induce erythroleukemia cell lines to undergo cell differentiation 
and cell death which the up-regulation of Apaf-1, caspase-3 and AChE activation might play 
a crucial role during the process of apoptosis in cancer cells [Cheng et al., 2004]. Apart from 
the above actions, it was also showed that Astragalus polysaccharides could counteract the 
side effects of chemotherapeutic drugs, such as a significant reduction in the degree of 
myelosuppression in cancer patients [Tin et al., 2007]. 
In general, RA was safe without any distinct adverse effects [Sinclair 1998; Yu et al., 2007]. 
4.11 Radix angelicae sinensis (Danggui in Chinese) 
Radix angelica sinensis (AS) is the dried root of Angelica sinensis (Oliv.) Diels 
(Umbelliferae) and is indigenous to China. AS is rarely available in the wild and is currently 
cultivated and harvested in late autumn after three years. It is mainly cultivated in Gansu 
province and partly in Yunnan, Sichuan, Shanxi, Hubei and Guizhou provinces of China. AS 
was first documented in Shen Nong Ben Cao Jing around 100 A.D.. According to the 
medicinal theory of traditional Chinese medicine, AS is used to tonify blood, improve blood 
circulation, regulate menstruation, and lubricate the bowels to alleviate constipation. 
Clinically, it has been commonly applied to the treatment of gynecological disorders (such 
as menstrual disorders, anemia, premenstrual syndrome and menopause), cardiovascular 
diseases, cerebrovascular diseases, cancer and high blood pressure for a long time. It was 
first introduced into western countries in 1899 by Merck in the form of a liquid extract 
named “Eumenol” and is presently marketed the United States as a dietary supplement, 
with numerous related commercial products for women’s care worldwide [Deng et al., 
2006].  
Currently, over 70 compounds have been isolated from AS and identified [Dong et al., 2007]. 
The main chemical constituents of AS are ferulic acid, ligustilide, angelicide, brefeldin A, 
butylidenephthalide, butyphthalide, succinic acid, nicotinic acid, uracil, and adenine. The 
constituents most often associated with the pharmacological activities of AS are ferulic acid 
and ligustilide (predominantly the Z-isomer), both  of which are usually used as chemical 
markers for the quality control of AS [Liu et al., 2000; Song, 1996]. 
Clinical studies showed that AS had anti-cancer capabilities in various human cancers. One 
study showed the inhibitory effect of AS on growth and proliferation of glioblastoma 
multiforme (GBM). The lipid-soluble ingredients of AS were extracted with acetone (AS-AC) 
or chlorophenol (AS-CH) and their antiproliferative and proapoptotic effects were studied 
in cultured GBM 8401 cells and in tumors in nude mice. Both extracts significantly inhibited 
the proliferative activity of GBM 8401 cultured cells by decreasing the expression of VEGF 
and the proapoptotic protein, cathepsin B, as this compound induced cancer cell cycle arrest 
at the G0-G1 phase which led to apoptosis. Both fractions significantly inhibited microvessel 
formation in the tumors of nude mice [Lee et al., 2006]. Growth suppression of malignant 
brain tumor cells by AS-CH resulted from cell cycle arrest and apoptosis. AS-CH up-
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regulated expression of cdk inhibitors, including p21, to decrease phosphorylation of Rb 
proteins which resulted in cell cycle arrest at the G0-G1 phase in human DBTRG-05MG and 
rat RG2 cells. The apoptosis-associated proteins were dramatically increased and activated 
in DBTRG-05MG cells and RG2 cells by AS-AC but without p53 protein expression in RG2 
cells. In vitro results showed that AS-AC triggered both p53-dependent and p53-
independent pathways of apoptosis [Tsai et al., 2005, 2006]. AS-AC and AS-CH also 
significantly inhibited microvessel formation in vivo. All these findings suggested that AS 
possessed anti-tumor effects and might be useful in the treatment of high-grade 
astrocytomas. It has been found that neodiligustilide, Z-ligustilide, 11(S), 16(R)-dihydroxy-
octadeca-9Z, 17-dien-12, 14-diyn-1-yl acetate and 3(R),8(S)-falcarindiol possess cytotoxic 
properties (Chen et al., 2007) .  
N-Butylidenephthalide (BP), isolated from the chloroform extract of AS, was examined for 
its antitumor effects on hepatocellular carcinoma cells and might be a potential clinical use 
for improving the prognosis of hepatocellular carcinoma cells by inducing apoptosis in 
carcinoma cells in vitro and in vivo [Chen et al., 2008]. Invasion and metastasis are essential 
characteristics of malignant tumors. An experimental study suggested that total 
polysaccharide of AS (ASP) possessed anti-tumor effects on experimental tumor models in 
vivo and inhibitory effects on invasion and metastasis of hepatocellular carcinoma cells in 
vitro [Shang et al., 2003]. AP promoted the release of NO, TNF-ǂ, and ROS and improved 
the activity of iNOS and lysozyme in macrophages. However, ASP had no direct 
cytotoxicity to tumor cells, but the culture medium of macrophages, pretreated with ASP, 
killed L929 tumor cells [Yang et al., 2004]. These results indicate that the extract may directly 
inhibit the invasion and metastasis of cancer cells, and indirectly stimulate immunological 
activity against cancer cell growth. Cell- mediated immune defense plays a key role in anti-
tumor activity and is mediated specifically by T cells and non-specifically by macrophages 
and natural killer (NK) cells [Shan et al., 2002; Wang et al., 2004]. A study found that ASP 
had immunomodulatory activity by regulating expression of Th1 and Th2 related cytokines. 
The time–effect relation of cytokines response also suggested that macrophages and natural 
killer cells involved in nonspecific immunity were primarily activated, and helper T cell 
were secondarily affected by ASP [Yang et al., 2006].  
AS contains several coumarin derivatives and should be used with caution in women on 
anticoagulants because of the increased risk of bleeding. AS also contains a carcinogenic 
essential oil, and some recommend that “all unnecessary exposure to dong quai should be 
avoided” [Israel et al., 1997]. The irritant agents in AS are believed to be the essential oils 
and Ligustilide is the most irritant within the essential oils of AS. An excess amount of 
ligustilide results in nausea, xeransis, and anesthesia of the oral cavity and tongue [Xie, 
1997]. 
4.12 Radix Salvia miltiorrhizae (Red Sage Root, Danshen in Chinese) 
Danshen is the root and rhizome of Salvia miltiorrhiza Bge. (Labiatae), mainly produced in 
Hebei, Shanxi, Inner Mongolia, Liaoning, and Jilin of China. The herb is collected in spring 
or autumn and dried in the sun. Traditinally, Danshen can be used in menstrual disorders, 
subcutaneous infection and insomnia by removing blood stasis, relieveing pain and easing 
the mind. 
In photochemistry, at least 80 compounds have been separated and identified from 
Danshen, including lipophilic compounds and hydrophilic compounds. Tanshinone IIA and 
Salvianolic Acid B are the main component and are credited as criteria for quality control of 
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Danshen in China Pharmacopeia (Edition 2005).Danshen is one of the most popular herbs in 
China. It has been widely applied for many years to treat various diseases by its 
neuroprotective, antimicrobial, cardiovascular, hepatoprotective, antiinflammatory and 
immunomodulatory effects, especially in cardiovascular and cerebrovascular disease (Feng 
et al., 2010). In recent years, danshen and its active compounds also showed anticancer 
effects as mentioned follows. 
The aqueous extract of Danshen can inhibit the proliferation of HepG2 cells (Jiang et al., 
2005). Salvinal, a compound identified from aqueous extract, inhibiting tubulin 
polymerization, arresting the cell cycle at mitosis, and inducing apoptosis in multidrug-
sensitive and -resistant human tumor cells (Chang et al., 2004). Another hydrophilic 
component Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in 
vitro and in vivo via inhibiting cyclooxygenase-2 expression (Hao et al., 2009). The chi-shen 
extract (CSE) from the water-soluble compounds of Salvia miltiorrhiza and Paeoniae radix 
shows anticancer effects which are related to the Bcl-2 family pathway and the activation of 
caspases-3 and -9 in HepG2 cells (Hu et al., 2007). Tanshinone IIA can induce apoptosis in 
HL60, CNE1, SPC-A-1, NB4, K562 and HepG2 cell lines, and the cytotoxicity partly through 
mitotic arrest or activation of capspase 3 (Yoon et al., 1999; Yuan et al., 2003; Lee et al., 2008; 
Zhou et al., 2008 ). Tanshinone IIA can inhibite the proliferation of non-small cell lung 
cancer A549 cells which is possibly by decreasing the MMP and inducing apoptosis due to 
the induction of a higher ratio of Bax/Bcl-2 (Chiu and Su 2010). Tanshinone I induces 
apoptosis, suppresses growth and invasion in MCF-7 and MDA-MB-231 breast cancer cell 
line, and its effect may be partly through activation of caspase 3 and regulation of some 
adhesion molecules, including intercellular adhesion molecule-1 (ICAM-1) and vascular cell 
adhesion molecule-1 (VCAM-1). Tanshinone I also exerts anticancer effect via mediation of 
interleukin-8, Ras-mitogen-activated protein kinase, and Rac1 signaling pathways in highly 
invasive human lung adenocarcinoma cell line, CL1-5 and CL1-5-bearing severe combined 
immunodeficient mice (Lee et al., 2008). Furthermore, other tanshinones, such as 
sibiriquinone A, sibiriquinone B, cryptotanshinone, and dihydrotanshinone I possess the 
anticancer activity partly through inhibition of HIF-1 accumulation (Dat et al., 2007). 
Recentlly, a novel compound, acetyltanshinone IIA (ATA) was obtained from chemical 
modifications of tanshinone TIIA (TIIA) which shows a higher growth inhibition ability on 
breast cancer especially HER2 positive cells than normal cells and it inhibites xenografted 
tumor growth in mice due to significant reactive oxygen species (ROS) generation, Bax 
translocation to mitochondria, resulting in mitochondria damage, cytochrome c release, 
caspase-3 activation and apoptotic cell death (Tian et al., 2010). 
Denshen has low toxicity and less side effects in clinical practice. LD50 of Danshen water 
extract for mice: 25.807 g/kg by oral administration. This LD50 value is equivalent to 3934 
times the intended clinical human oral dosage (6.56 mg of Danshen extract/kg). Treating 
rats with an oral dose of 2500 mg/kg Danshen extract (400 times human oral dosage) for 90 
days have been found to be nontoxic (Tianjin Talisco Pharmaceutical Group Co. Ltd., 1998). 
5. Conclusion 
Chinese medicine is an unique medical system, among which Chinese medicines have been 
used in main stream medical health care in China for years of thousands and have been 
accepted by many countries as an complemental and alternative medicine. On the other 
hand, Chinese medicines are also as a resource in new drug develupment for unmet medical 
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needs in some hard-to-cure diseases. In this chapter, we reviewed the recent progress of 
twelve representative Chinese medicines  (Rhizoma coptidis, arsenic, Rhizoma Curcuma 
longae, Radis stephaniae tetrandrae, Radix tripterygii wilfordii, Radix scutellariae, Herba 
artemisiae annuae, Radix ginseng, Radix notoginseng, Radix astragali, Radix angelicae 
senensis and Radix salviae miltiorrhizae) on the anticancer cellular and molecular 
mechanisms, major active chemical ingredients and adverse effects. We noted that safety, 
quality control and sustainable develupment should be stressed in Chinese medicines 
research. On the other hand, research mainly focused on sigle Chinese medicines in the past 
decades, we should do more studies on composite fomulae in the future. After reviewing 
hot Chinese medicines in treatment of cancer in this chapter, we hope it will lead to further 
exploration of Chinese medicines by advanced scientific technology in drug discovery for 
treating cancer in the worldwide. 
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